Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JPH034 SAD and Food Effect Study in Healthy Adults
NCT07534657Phase 1Recruiting
- Sponsor
- J-Pharma
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of JPH034 (6 arms), sponsored by J-Pharma. Primary endpoints: Adverse Events at Day 9, Discontinuation of Study Intervention at Day 9 and 6 more. Started Mar 2026; status: recruiting.
02
Drugs
JPH034
Beyond the preview
Go deeper on NCT07534657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07534657.